Gene · 4585
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential Ability of Probiotics in the Prevention and Treatment of Colorectal Cancer. | Clin Med Insights Oncol | 2023 | 37601319 | PubTator, text mining | PubMed |
| Association of PIK3CA mutation with outcomes in HER2-positive breast cancer treated with anti-HER2 therapy: A meta-analysis and bioinformatic analysis of TCGA‑BRCA data. | Transl Oncol | 2023 | 37597296 | PubTator, text mining | PubMed |
| Clustering of diet, physical activity and sedentary behaviour and related physical and mental health outcomes: a systematic review. | BMC Public Health | 2023 | 37596591 | PubTator, text mining | PubMed |
| The role of gastric microecological dysbiosis in gastric carcinogenesis. | Front Microbiol | 2023 | 37583514 | PubTator, text mining | PubMed |
| Layer-by-layer coating of natural diatomite with silver nanoparticles for identification of circulating cancer protein biomarkers using SERS. | Nanoscale | 2023 | 37578149 | PubTator, text mining | PubMed |
| First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial. | Nat Med | 2023 | 37563240 | PubTator, text mining | PubMed |
| Glycosylated extracellular mucin domains protect against SARS-CoV-2 infection at the respiratory surface. | PLoS Pathog | 2023 | 37561789 | PubTator, text mining | PubMed |
| Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial. | BMC Med | 2023 | 37559142 | PubTator, text mining | PubMed |
| Mutational landscape of cancer-driver genes across human cancers. | Sci Rep | 2023 | 37550388 | PubTator, text mining | PubMed |
| Identification and validation of a novel HOX-related classifier signature for predicting prognosis and immune microenvironment in pediatric gliomas. | Front Cell Dev Biol | 2023 | 37547473 | PubTator, text mining | PubMed |
| Multi-omics integrated analyzed the origin of intrahepatic mucinous cholangiocarcinoma: a case report. | Front Oncol | 2023 | 37546424 | PubTator, text mining | PubMed |
| MFSD2A potentiates gastric cancer response to anti-PD-1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response. | Cancer Commun (Lond) | 2023 | 37539769 | PubTator, text mining | PubMed |
| Anoikis resistance--protagonists of breast cancer cells survive and metastasize after ECM detachment. | Cell Commun Signal | 2023 | 37537585 | PubTator, text mining | PubMed |
| Identification of genes critical for inducing ulcerative colitis and exploring their tumorigenic potential in human colorectal carcinoma. | PLoS One | 2023 | 37535606 | PubTator, text mining | PubMed |
| Analysis of somatic mutations and key driving factors of cervical cancer progression. | Open Med (Wars) | 2023 | 37533736 | PubTator, text mining | PubMed |
| Review and Application of Integrin Alpha v Beta 6 in the Diagnosis and Treatment of Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma. | Technol Cancer Res Treat | 2023 | 37525872 | PubTator, text mining | PubMed |
| Penoscrotal Low-grade fibromyxoid sarcoma, A case report. | Urol Case Rep | 2023 | 37521276 | PubTator, text mining | PubMed |
| Deciphering and targeting host factors to counteract SARS-CoV-2 and coronavirus infections: insights from CRISPR approaches. | Front Genome Ed | 2023 | 37520399 | PubTator, text mining | PubMed |
| Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma. | Genes (Basel) | 2023 | 37510286 | PubTator, text mining | PubMed |
| Bile Acids and Microbiota Interplay in Pancreatic Cancer. | Cancers (Basel) | 2023 | 37509236 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4585/papers?page=22